KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial - West, N; Hemmings, G; Richman, S; Taylor, M; Chambers, P; Magill, L; Lancaster, D; Taniere, P; Handley, K; Brown, G; Ferry, D; Seymour, M; et al. (JOURNAL OF PATHOLOGY, 2012)